EHRs Creating a ‘New Era’ of Healthcare Fraud
The federal government funneled billions in subsidies to software vendors and some overstated or deceived the government about what their products could do, according to whistleblowers.
Related Articles
Noninvasive focused ultrasound show potential for combating chronic pain
Chronic pain impacts an estimated 20% of the world population and persists as a frustrating symptom for innumerable health issues, from sickle-cell disease to arthritis.
Cerebrospinal fluid flow extends to peripheral nerves further unifying the nervous system
Cerebrospinal fluid unites the nervous system by extending beyond the central nervous system into peripheral nerves.
Cerebrospinal fluid flow extends to peripheral nerves further unifying the nervous system
Cerebrospinal fluid unites the nervous system by extending beyond the central nervous system into peripheral nerves.
What doctors wish patients knew about preventing falls
Fall prevention goes beyond just individual efforts. It includes your physician too. Jason Hill, MD, a hospitalist at Ochsner Health, shares more.
Can amylin drugs best Wegovy and Zepbound? Companies bet on next big obesity target
Looking for successors to the blockbuster GLP-1 obesity drugs, companies like Novo Nordisk and Eli Lilly are testing amylin hormone receptor treatments. The hope is…
Cerebrospinal fluid flow extends to peripheral nerves further unifying the nervous system
Cerebrospinal fluid unites the nervous system by extending beyond the central nervous system into peripheral nerves.
Cerebrospinal fluid flow extends to peripheral nerves further unifying the nervous system
Cerebrospinal fluid unites the nervous system by extending beyond the central nervous system into peripheral nerves.
Can amylin drugs best Wegovy and Zepbound? Companies bet on next big obesity target
Looking for successors to the blockbuster GLP-1 obesity drugs, companies like Novo Nordisk and Eli Lilly are testing amylin hormone receptor treatments. The hope is…
Can amylin drugs best Wegovy and Zepbound? Companies bet on next big obesity target
Looking for successors to the blockbuster GLP-1 obesity drugs, companies like Novo Nordisk and Eli Lilly are testing amylin hormone receptor treatments. The hope is…
Late-onset major depressive disorder: exploring the therapeutic potential of enhancing cerebral brain-derived neurotrophic factor expression through targeted microRNA delivery
Translational Psychiatry – Late-onset major depressive disorder: exploring the therapeutic potential of enhancing cerebral brain-derived neurotrophic factor expression through targeted microRNA…